Atlas Trials

A Study to Assess Renal Function Response to Treatment in Patients With Relapsed Multiple Myeloma and Creatinine Clearance

Clinical trial NCT02849444 · COMPLETED

Trial details

NCT number
NCT02849444
Sponsor
Celgene
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2012-09-23
Primary completion
2019-12-23
Enrollment
326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.